Prenetics

👥 251-500💰 $120,000,000 Post-IPO Equity over 2 years agoPersonal HealthBiotechnologyWellnessHealth CareGeneticsHealth Diagnostics📈 Public Company
Website LinkedIn Email Facebook Twitter

Prenetics is a leading genomics-driven health sciences company focused on revolutionizing health through prevention, early detection, and treatment. With innovative products like CircleDNA, a comprehensive consumer DNA test, and Insighta, a joint venture aimed at early cancer detection, Prenetics is committed to enhancing global health through advanced scientific solutions.

Related companies: